|
XIST expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.54389883894646E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.28309998579124E-09 |
| Normal-vs-Stage2 |
4.136500E-02 |
| Normal-vs-Stage3 |
2.953600E-04 |
| Normal-vs-Stage4 |
4.980100E-03 |
| Stage1-vs-Stage2 |
3.219800E-01 |
| Stage1-vs-Stage3 |
7.844800E-01 |
| Stage1-vs-Stage4 |
3.801400E-01 |
| Stage2-vs-Stage3 |
5.070800E-01 |
| Stage2-vs-Stage4 |
8.296000E-01 |
| Stage3-vs-Stage4 |
5.985800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89509996584292E-09 |
| Normal-vs-AfricanAmerican |
7.437300E-04 |
| Normal-vs-Asian |
1.109790E-01 |
| Caucasian-vs-AfricanAmerican |
3.672800E-01 |
| Caucasian-vs-Asian |
2.396400E-01 |
| AfricanAmerican-vs-Asian |
4.486200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.277870E-03 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
1.62436730732907E-12 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.068000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.12010000000262E-06 |
| Normal-vs-Age(61-80Yrs) |
9.01709995559941E-09 |
| Normal-vs-Age(81-100Yrs) |
4.645900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.754700E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.00169999999833E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.754000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.669600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.155800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.871000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.967750E-02 |
| Normal-vs-Grade 2 |
3.02949998420843E-10 |
| Normal-vs-Grade 3 |
1.543900E-03 |
| Normal-vs-Grade 4 |
1.622330E-02 |
| Grade 1-vs-Grade 2 |
1.371580E-01 |
| Grade 1-vs-Grade 3 |
6.178100E-02 |
| Grade 1-vs-Grade 4 |
8.137800E-02 |
| Grade 2-vs-Grade 3 |
1.358670E-03 |
| Grade 2-vs-Grade 4 |
4.627900E-02 |
| Grade 3-vs-Grade 4 |
6.811200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.1820000533902E-10 |
| Normal-vs-ccB subtype |
4.372400E-02 |
| ccA subtype-vs-ccB subtype |
2.95009999995433E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.60500001967057E-09 |
| Normal-vs-N1 |
3.032200E-01 |
| N0-vs-N1 |
4.015600E-01 |
|
|
